Kevin Bitterman, Director at Genocea Biosciences, holds 926.83K shares in Disc Medicine (Ticker: IRON), holds 2.52M shares in Akero Therapeutics (Ticker: AKRO), holds 4.16M shares in Editas Medicine (Ticker: EDIT). Most recently, Kevin Bitterman Sold ― shares of Disc Medicine on Mar 07, 2024 for an estimated value of 1.92M.